3.09 pm | 14 Dec 2007 |  Source: Moneycontrol.com

Gaurang Shah of Geojit Financial Services is of the view that one can exit Cadila Healthcare on upside. There are not positive triggers going forward....

2.29 pm | 14 Dec 2007 |  Source: Moneycontrol.com

Anu Jain of Omniscient Securities is of the view that one can hold Cadila Healthcare for short term. There is no point of booking up now. But at anoth...

3.11 pm | 11 Dec 2007 |  Source: Moneycontrol.com

Rajesh Jain of SMC Global Securities is of the view that Cadila Healthcare has support at Rs 260-280. It has been moving sideways since last two-years...

1.20 pm | 02 Nov 2007

Indian Pharma Industry a continuing success story...

2.43 pm | 26 Oct 2007 |  Source: Moneycontrol.com

Cadila Health in Q2 FY08 has posted consolidated net sales of Rs 609.7 crore versus Rs 474.8 crore on YoY basis. During the corresponding quarters, i...

8.47 am | 13 Sep 2007

India’s Lupin has won its patent challenge against King Pharmaceuticals and Sanofi-Aventis for blood pressure drug Altace, which has sales of $700...

4.30 pm | 11 Sep 2007

Sun Pharma has received USFDA nod to market Pantoprazole tablets, which is the generic version of Wyeth's Protonix. Pantoprazole is an anti-ulcer drug...

12.42 pm | 21 Aug 2007

CNBC-TV18 has learnt that Cadila Healthcare is eyeing acquisitions in Europe and the US. ...

12.48 pm | 16 Aug 2007

Karvy Stock Broking firm has recommended buy rating on the stock and expects target price of Rs 455....

5.22 pm | 31 Jul 2007

Cadila Healthcare has come out with first quarter consolidated results. The company organised a conference call to discuss its results and future guid...

2.42 pm | 31 Jul 2007

Cadila Healthcare has come out with first quarter consolidated results. It has reported net profit of Rs 73.9 crore for first quarter as against Rs 58...

8.42 am | 27 Jul 2007

After acquiring companies in Japan and Brazil this year in its quest to emerge among the top 10 global generic companies with sales of $1 billion ...

5.48 pm | 25 Jun 2007

Zydus Cadila acquires Brazilian company Nikkho...

12.20 pm | 25 Jun 2007

Zydus Cadila has acquired Brazil-based generic company, Nikkho Pharma, for $25 million. The Brazilian generic market is estimated at $500 mill...

1.38 pm | 19 Jun 2007

Cadila Healthcare is planning to raise $100 million (approx. Rs 400 crore) for overseas acquisition, reports CNBC-TV18. The company will issue FCC...

9.37 am | 14 Jun 2007

Sharekhan Research is bullish on Cadila Healthcare and has maintained buy rating on the stock with target of Rs 425....

2.37 pm | 23 May 2007

Govt to issue notices to 331 drug companies for over-pricing their drugs. Govt to issue notice to Cadila, Torrent and DRL on over-pricing....

12.02 pm | 30 Apr 2007

Broking house, Karvy Stock Broking has recommended an outperformer rating on Cadila Healthcare with a target of Rs 400....

11.14 am | 30 Apr 2007

Broking house, Angel Broking is bullish on Cadila Healthcare and has maintained buy rating on the stock with a target of Rs 430....

10.42 am | 30 Apr 2007

Broking house, Edelweiss Research has maintained accumulate rating on Cadila Healthcare....